Business Context and Reporting Period
This Form 8-K Current Report was filed by Organogenesis Holdings Inc. on February 18, 2026. The filing addresses corporate governance changes under Item 5.02 regarding the appointment of a new Chief Accounting Officer and the departure of the previous principal accounting officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Appointment: Patrick McGuire was appointed as Chief Accounting Officer and principal accounting officer, effective February 18, 2026.
- Departure: David Francisco ceased serving as principal accounting officer on February 18, 2026, though he continues as Chief Financial Officer and principal financial officer.
- Compensation: Patrick McGuire's annual base salary was increased to $345,000 in connection with his appointment. No other compensation changes were made.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. It is a standard disclosure of an executive appointment and role transition.
Investor Verification Checklist
- Verify the effective date of Patrick McGuire's appointment as Chief Accounting Officer (February 18, 2026).
- Confirm David Francisco's continued role as Chief Financial Officer following his departure as principal accounting officer.
- Note the specific base salary adjustment for the new Chief Accounting Officer ($345,000).
- Review the Company's most recent 10-K or 10-Q for financial metrics, as this 8-K does not contain them.